110 related articles for article (PubMed ID: 1582444)
1. Alterations in lipoprotein density classes in infantile visceral leishmaniasis: presence of apolipoprotein SAA.
Bekaert ED; Dole E; Dubois DY; Bouma ME; Lontie JF; Kallel R; Malmendier CL; Ayrault-Jarrier M
Eur J Clin Invest; 1992 Mar; 22(3):190-9. PubMed ID: 1582444
[TBL] [Abstract][Full Text] [Related]
2. Plasma lipoproteins in infantile visceral leishmaniasis: deficiency of apolipoproteins A-I and A-II.
Bekaert ED; Kallel R; Bouma ME; Lontie JF; Mebazaa A; Malmendier CL; Ayrault-Jarrier M
Clin Chim Acta; 1989 Sep; 184(2):181-91. PubMed ID: 2514050
[TBL] [Abstract][Full Text] [Related]
3. SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice.
Cabana VG; Reardon CA; Wei B; Lukens JR; Getz GS
J Lipid Res; 1999 Jun; 40(6):1090-103. PubMed ID: 10357841
[TBL] [Abstract][Full Text] [Related]
4. Serum amyloid A-containing human high density lipoprotein 3. Density, size, and apolipoprotein composition.
Coetzee GA; Strachan AF; van der Westhuyzen DR; Hoppe HC; Jeenah MS; de Beer FC
J Biol Chem; 1986 Jul; 261(21):9644-51. PubMed ID: 3525531
[TBL] [Abstract][Full Text] [Related]
5. Serum Amyloid A Is an Exchangeable Apolipoprotein.
Wilson PG; Thompson JC; Shridas P; McNamara PJ; de Beer MC; de Beer FC; Webb NR; Tannock LR
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1890-1900. PubMed ID: 29976766
[TBL] [Abstract][Full Text] [Related]
6. Visceral leishmaniasis is associated with marked changes in serum lipid profile.
Liberopoulos EN; Apostolou F; Gazi IF; Kostara C; Bairaktari ET; Tselepis AD; Elisaf M
Eur J Clin Invest; 2014 Aug; 44(8):719-27. PubMed ID: 24920396
[TBL] [Abstract][Full Text] [Related]
7. Role of serum amyloid A during metabolism of acute-phase HDL by macrophages.
Artl A; Marsche G; Lestavel S; Sattler W; Malle E
Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):763-72. PubMed ID: 10712402
[TBL] [Abstract][Full Text] [Related]
8. Effects of androgenic-anabolic steroids on apolipoproteins and lipoprotein (a).
Hartgens F; Rietjens G; Keizer HA; Kuipers H; Wolffenbuttel BH
Br J Sports Med; 2004 Jun; 38(3):253-9. PubMed ID: 15155420
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of apolipoproteins B, C-I, C-II, C-III and E in sera from normal men and their relation to serum lipoprotein levels.
Carlson LA; Holmquist L
Clin Chim Acta; 1982 Sep; 124(2):163-78. PubMed ID: 6754139
[TBL] [Abstract][Full Text] [Related]
10. Apolipoproteins as the basis for heterogeneity in high-density lipoprotein2 and high-density lipoprotein3. Studies by isoelectric focusing on agarose films.
Marcel YL; Weech PK; Nguyen TD; Milne RW; McConathy WJ
Eur J Biochem; 1984 Sep; 143(3):467-76. PubMed ID: 6479161
[TBL] [Abstract][Full Text] [Related]
11. Ezetimibe decreases serum amyloid A levels in HDL3 in hemodialysis patients.
Hirano T; Nohtomi K; Nakanishi N; Watanabe T; Hyodo T; Taira T
Clin Nephrol; 2010 Oct; 74(4):282-7. PubMed ID: 20875380
[TBL] [Abstract][Full Text] [Related]
12. Acute phase proteins and plasma lipoproteins during antimony treatment in infantile visceral leishmaniasis.
Kallel R; Bekaert ED; Dubois DY; Alcindor LG; Ayrault-Jarrier M; Mebazza A
Clin Physiol Biochem; 1993; 10(1):8-12. PubMed ID: 8339522
[TBL] [Abstract][Full Text] [Related]
13. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
[TBL] [Abstract][Full Text] [Related]
14. Distribution of lipids and apolipoproteins in human plasma by vertical spin ultracentrifugation.
Campos E; McConathy WJ
Arch Biochem Biophys; 1986 Sep; 249(2):455-63. PubMed ID: 3753012
[TBL] [Abstract][Full Text] [Related]
15. A density gradient study of the lipoprotein and apolipoprotein distribution in the chicken, Gallus domesticus.
Hermier D; Forgez P; Chapman MJ
Biochim Biophys Acta; 1985 Aug; 836(1):105-18. PubMed ID: 4027256
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein and lipoprotein concentrations in familial apolipoprotein C-II deficiency.
Breckenridge WC; Alaupovic P; Cox DW; Little JA
Atherosclerosis; 1982 Aug; 44(2):223-35. PubMed ID: 7138621
[TBL] [Abstract][Full Text] [Related]
17. Serum lipoprotein and apolipoprotein profiles of the genetically obese ob/ob mouse.
Camus MC; Aubert R; Bourgeois F; Herzog J; Alexiu A; Lemonnier D
Biochim Biophys Acta; 1988 Jul; 961(1):53-64. PubMed ID: 3382693
[TBL] [Abstract][Full Text] [Related]
18. Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids.
Baldo-Enzi G; Giada F; Zuliani G; Baroni L; Vitale E; Enzi G; Magnanini P; Fellin R
Metabolism; 1990 Feb; 39(2):203-8. PubMed ID: 2105436
[TBL] [Abstract][Full Text] [Related]
19. Acute changes in lipid, lipoprotein, apolipoprotein, and low-density lipoprotein particle size after an endurance triathlon.
Lamon-Fava S; McNamara JR; Farber HW; Hill NS; Schaefer EJ
Metabolism; 1989 Sep; 38(9):921-5. PubMed ID: 2505019
[TBL] [Abstract][Full Text] [Related]
20. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
Bard JM; Parra HJ; Douste-Blazy P; Fruchart JC
Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
